Healthy adults
Conditions
Interventions
Intake of test food 1 (single ingestion) - washout period - intake of test food 2 (single ingestion) - washout period - intake of test food 3 (single ingestion).
Intake of test food 2 (single ingestio
Sponsors
DRC Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Males and females aged 20 to 60 years. 2. Subjects who are Generally healthy. 3. Subjects who can voluntarily provide written consent to participate in the study.
Exclusion criteria
Exclusion criteria: 1.Subjects who are continuously consuming health foods, quasi-drugs, or medicines that claim or emphasize efficacy or effects similar to or related to the efficacy being investigated in this study. 2.Subjects who have changed or newly started using health foods within the past four weeks. 3.Subjects engaged in night shifts or rotating day and night shifts. 4.Subjects who, at the time of consent acquisition, are receiving treatment or preventive care at a medical institution (hormone replacement therapy, drug therapy, exercise therapy, diet therapy, etc.) or are judged to require treatment. 5.Subjects with, or with a history of, disorders of glucose metabolism, lipid metabolism, liver function, kidney function, heart, cardiovascular system, respiratory system, endocrine system, immune system, or nervous system. 6.Subjects with a history of alcohol or drug dependency. 7.Subjects at risk of developing an allergic reaction to almonds or other nuts. 8.Subjects who are pregnant, breastfeeding, or intend to become pregnant during the study period at the time of consent acquisition. 9.Subjects who have experienced discomfort or worsening of their condition due to blood collection in the past, or those who have been told that blood collection is difficult due to thin veins. 10.Subjects who have participated in other human trials (e.g., those involving foods, drugs, quasi-drugs, medical devices, etc.) within the past four weeks, or those planning to participate in another human trial during the scheduled study period. 11.Subjects who have difficulty consuming the test food (e.g., those unable to chew and consume almonds). 12.Subjects who are deemed inappropriate for participation by the principal investigator or study director.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Amount of vitamin E (as alpha-tocopherol) in blood, transfer rate (CMAX from 0h to 10h), and AUC 0-48h for postprandial serum total vitamin E concentrations. | — |
Countries
Japan
Contacts
Public ContactHiroaki Furusho
DRC Co., Ltd. Product Testing Department
Outcome results
None listed